Clinical Trials in Chronic Lymphocytic Leukaemia (CLL)

 

Trial Name

 

Trial Summary

 

Hyperlink

 

FLAIR

 

This trial is comparing ibrutinib alongside rituximab with fludarabine, cyclophosphamide, rituximab and venetoclax for chronic lymphocytic leukaemia. This trial is for people who haven’t yet had treatment for their chronic lymphocytic leukaemia (CLL)

 

More details

BGB-3111-304

This trial is for patients with untreated CLL, comparing the drug BGB-3111 with bendamustine and rituximab.

More details